Showing 311-320 of 2652 results for "".
Double Whammy
https://modernod.com/topics/patient-care/double-whammy/38878/Optic neuritis caused by multiple sclerosis is a diagnosis you don’t want to miss.Vision Correction Guidelines for Patients Approaching Presbyopia
https://modernod.com/topics/contact-lenses/vision-correction-guidelines-for-patients-approaching-presbyopia/38781/Boost your multifocal contact lens fitting rates with effective patient engagement.Eyenovia Celebrates First FDA Approval
https://modernod.com/articles/significant-findings/eyenovia-celebrates-first-fda-approval/37736/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatEntry Points Into Ocular Aesthetics
https://modernod.com/topics/business/entry-points-into-ocular-aesthetics/38622/Adding aesthetics to your practice can attract new patients and revenue, but it’s best to start small and build out.Alcon Acquires Staar for $1.5 Billion
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-acquires-staar-for-15-billion/37096/Alcon makes a major acquisition to expand its refractive portfolio; the CEO of Lenz Therapeutics joins us to discuss the FDA approval of a new presbyopia drop; and the optical industry braces for major changes as new reciprocal tariffs are set to begin this week. Learn more about your ad choices.Utilizing AI to Provide DR Screening to Underserved Communities
https://modernod.com/podcasts/eyewire-news-the-podcast/utilizing-ai-to-provide-dr-screening-to-underserved-communities/37079/EyewireTV speaks with the leaders of Digital Diagnostics and AEYE Health about their diabetic screening technology, racial and socioeconomic disparities in eye care, and their mission to improve health equity by expanding their technology into underserved populations. Learn more about your ad choiceFDA Approves First Treatment for MacTel
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-approves-first-treatment-for-mactel/37075/The CEO of Neurotech joins us to talk about the FDA approval of the first treatment for MacTel; a target action date is set for Sydnexis’ pediatric myopia treatment candidate; and three eye care companies collaborate to launch a wearable vision testing platform. Learn more about your ad choices. VisWhat to Do With Noncompliant Dry Eye Patients
https://modernod.com/podcasts/to-the-point/what-to-do-with-noncompliant-dry-eye-patients/36895/Do you have patients who find it difficult to stick with their dry eye treatment plans? In this episode of To the Point, Leslie and Jackie discuss how they have handled various noncompliant patient situations. The hosts also provide tips for increasing patient adherence to treatment plans and improvGut Check!
https://modernod.com/topics/nutritionpharmaceuticals/gut-check/38343/Maintaining a healthy intestinal microbiome can lower the chances of developing common metabolic diseases with ocular findings.Antioxidant Molecule Under Evaluation for Delaying Cataract Progression
https://modernod.com/articles/significant-findings/antioxidant-molecule-under-evaluation-for-delaying-cataract-progression/37743/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat